All patients in pembrolizumab trial were found to be cancer-free after combination of drug and surgery
A “gamechanger” immunotherapy drug that “melts away” tumours dramatically increases the chances of curing bowel cancer and may even replace the need for surgery, doctors have said.
Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells.
More Stories
Bees face new threats from wars, street lights and microplastics, scientists warn
Bankrupt DNA testing firm 23andMe to be purchased for $256m
Sea level rise will cause ‘catastrophic inland migration’, scientists warn